Our “highly regarded” life sciences arbitration lawyers are renowned for their “expert handling of life sciences disputes” (Chambers 2020), and “understanding of the needs of life sciences companies” (Legal 500 USA 2022).

From strategically drafting arbitration clauses and formulating dispute avoidance strategies, to effectively representing life sciences companies before arbitral tribunals and courts in related litigation, our life sciences arbitration team can help you successfully navigate all phases of a cross-border life sciences dispute, including disputes with foreign governments.

In addition to acting as counsel, members of our life sciences arbitration team routinely sit as arbitrators and play leading roles in major arbitral institutions. We are recognized globally as thought leaders in the arbitration arena, affording us unique tools for effectively resolving life sciences arbitrations and adding to our “strong experience across both advisory and contentious matters” (Chambers 2020).

We draw on expertise from across our multidisciplinary global life sciences practice – which represents eight of the top 10 largest pharmaceutical manufacturers, and eight of the top 10 largest medical device manufacturers, in the world – to build teams that provide holistic and comprehensive advice for life sciences arbitrations seated in the United States, Europe, Asia, the Middle East, Africa and Latin America under a host of governing laws.